Download 1st Lecture 1434

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Skin cancer wikipedia , lookup

Transcript
Pharmacology-4 PHL 425
First Lecture
By
Abdelkader Ashour, Ph.D.
Phone: 4677212
Email: [email protected]
Pigmentation Disorders, Introduction
 Normal skin color is composed of a mixture of four biochromes (biological pigments):
1. reduced hemoglobin (blue)
3. carotenoids (yellow; exogenous from diet)
2. oxyhemoglobin (red)
4. melanin (brown)
 The color of skin is principally genetically determined and is largely the result of the
insoluble polymeric pigment melanin produced by melanocytes in a highly
specialized organelle known as the melanosome
 Melanin is the dark pigment that gives skin its color and protects against UV radiation
 Melanocytes synthesize two chemically distinct groups of melanin:
I. nitrogenous eumelanins (black to brown)
II. sulfur-containing pheomelanins (yellow to reddish-brown)
 The type and amount of melanin and its distribution pattern in the surrounding
keratinocytes determine the actual color of the skin, and provide the basis of the
three principal human skin colors: black, brown and white
 These three basic skin colors are genetically determined and are called constitutive
melanin pigmentation
 The normal basic skin color pigmentation can be increased deliberately by exposure to
UVR or pituitary hormones, and this is called inducible melanin pigmentation
 The combination of the constitutive and inducible melanin pigmentation determines what is
called the skin phototype (SPT)
Melanocyte, Melanosome and Keratinocyte
 The melanocyte (pigment cell) resides in the basal layer of the surface layer
of the skin “ epidermis” and supplies melanin (packaged within
melanosomes) to surrounding keratinocytes. Following exposure to UV
light, there is an increase in the number of melanosomes, their melanin
content and their transfer to keratinocytes
Mechanism of pigment formation
UV
Epidermis
Melanocyte
Tyrosine
Tyrosinase
Melanin
Biosynthesis of Pheomelanin & Eumelanin
Melanocyte
MSH +
Tyrosinase
Dopa (
)
Tyrosinase
Dopachrome tautomerase
Tyrosinase
Modified from Lamoreux et al. Genetics 119: 967-984 August, 1986
Pigmentation Disorders, Introduction, contd.
 Increase of melanin in the epidermis results in a state known as hypermelanosis
(hyperpigmentation), which reflects one of two types of changes:
I. An increase in the number of melanocytes in the epidermis producing increased levels of
melanin, which is called melanocytotic hypermelanosis (an example is lentigo)
II. No increase of melanocytes but an increase in the production of melanin only, which is
called melanotic hypermelanosis (an example is melasma; also known as chloasma)
 Hypermelanosis of both types can result from three factors: genetic; hormonal (as in
Addison disease, when it is caused by an increase in circulating ACTH) and UVR (as in
tanning)
α- MSH (α-melanocortin) & ACTH are produced from a common precursor, proopiomelanocortin.
ACTH also enhances melanogenesis as it shares some structural similarity with a-MSH
 Hypomelanosis (depigmentation) is a decrease of melanin in the epidermis. This
reflects mainly two types of changes:
I. No decrease of melanocytes but a decrease of the production of melanin only that is called
melanopenic hypomelanosis (an example is albinism which is a congenital disease)
II. A decrease in the number or absence of melanocytes in the epidermis producing no or
decreased levels of melanin. This is called melanocytopenic hypomelanosis (an example is
vitiligo which is an acquired idiopathic disorder.)
 Hypomelanosis can result from genetic (as in albinism), from autoimmune (as in vitiligo), or
other inflammatory processes (as in postinflammatory leukoderma in psoriasis)
 Depigmentation could also be secondary such as burn and chemicals
Vitiligo
Pigmentation Disorders, Vitiligo
 Vitiligo (white spot disease) is a loss of skin melanocytes
that causes areas of skin depigmentation of varying sizes,
in various parts
 Clinically, It is characterized by totally white macules, which
enlarge and can affect the entire skin
Macule is an area of skin discoloration, without elevation or
depression and, therefore, nonpalpable. It may be of any
color, white or red for example. Macules may be the result of
hyperpigmentation or hypopigmentation
 Depigmentation may involve 1 or 2 spots (focal vitiligo),
entire body segments (segmental vitiligo), or rarely most of
the skin surface (universal vitiligo)
 It most commonly involves:
The face, digits, dorsal hands, elbows, armpits,
Knees, dorsal ankles, inguinal area,
Anogenital area, umbilicus and nipples,
 Hair in vitiliginous areas is usually white
Vitiligo, Symptoms & Signs

Cosmetic disfigurement, particularly in darker
skinned individuals, is a psychosocial disaster

White patches of skin

Whitening or graying of the hair on scalp,
eyelashes, eyebrows or beard
Vitiligo, Etiology

The cause is unknown, but the condition may be autoimmune process, in which the
body destroys its own melanocytes, since autoantibodies to melanocytes were
identified & up to 1/3 of patients have evidence of other autoimmune disease (e.g.,
Addison's disease, diabetes mellitus, pernicious anemia & thyroid dysfunction)
 Predisposing factors:

Heredity
Vitiligo has a genetic background; >30% of affected individuals have
reported vitiligo in a parent, sibling or child
Individuals from families with an increased prevalence of thyroid disease,
diabetes mellitus, and vitiligo appear to be at increased risk for development of
vitiligo
Physical trauma (where vitiligo appears at the site of trauma; Koebner
phenomenon),
 Exposure to chemicals such as phenols
 Illness or emotional stress
 Skin injury, burns or inflammatory skin disorders
A sunburn reaction may precipitate vitiligo

Vitiligo, Epidemiology, Course & Prognosis
 Vitiligo affects 0.5 to 2% of the population worldwide. Epidemiology is equal in both
sexes and in all races
 Vitiligo is a chronic disease. It is commonly characterized by rapid onset followed by
a period of stability or slow progression
 Up to 30% of patients may report some spontaneous repigmentation in a few areas,
particularly areas that are exposed to the sun
 Rapidly progressive, or "galloping," vitiligo may quickly lead to extensive
depigmentation with a total loss of pigment in skin and hair, but not eyes
 All depigmented areas are prone to severe sunburn and must be protected with
clothing or sunscreen
 Cosmetic disfigurement can be devastating, especially in dark-skinned patients
 The treatment of vitiligo-associated disease (i.e., thyroid disease) has no impact on
the course of vitiligo